Sugi Predict

Sugi Predict / Compounds / SCHEMBL19106437

SCHEMBL19106437

SCHEMBL19106437

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccc6c(ccc7ccccc76)c5)c4)c4c(n3)sc3ccccc34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.36
▸ ADORA1 P30542 2/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ ERBB2 P04626 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ F9 P00740 3/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ HPGD P15428 3/20 0.33
▸ ELANE P08246 1/20 0.33
▸ MEN1 O00255 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106414 0.95 CYP1A2 (0.35) ADORA2AADORA1CYP1A2ERBB2FYN
SCHEMBL19106394 0.95 MEN1 (0.36) ADORA2AADORA1CYP1A2ERBB2FYN
SCHEMBL19106467 0.94 CYP1A2 (0.34) ADORA2AADORA1CYP1A2ERBB2FYN
SCHEMBL19106423 0.94 CYP1A2 (0.35) ADORA2AADORA1CYP1A2ERBB2FYN
SCHEMBL19106461 0.93 F9 (0.34) ADORA2AADORA1CYP1A2ERBB2FYN
SCHEMBL19106441 0.92 MEN1 (0.37) ADORA2AADORA1CYP1A2ERBB2FYN
SCHEMBL18017921 0.92 ADORA2A (0.42) ADORA2AADORA1NPC1LMNARAB9A
SCHEMBL18370728 0.92 ADORA2A (0.42) ADORA2AADORA1NPC1LMNARAB9A
SCHEMBL18017919 0.92 ADORA2A (0.42) ADORA2AADORA1NPC1LMNARAB9A
SCHEMBL19106428 0.92 ADORA2A (0.42) ADORA2AADORA1NPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 ADORA2A 4441/4885ADORA1 4054/4885CYP1A2 1060/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 ADORA2A 4441/4885ADORA1 4054/4885CYP1A2 1060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback